Pharmaceutical composition for treating diabetes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9290487
APP PUB NO 20140336376A1
SERIAL NO

14268323

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a compound represented by the following general formula (I), or a pharmaceutically acceptable salt thereof. This novel compound has a glycogen-synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EA PHARMA CO LTD2-1-1 IRIFUNE CHUO-KU TOKYO 104-0042

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Inoue, Hiroki Kawasaki, JP 265 2531
Kobayashi, Kaori Kawasaki, JP 21 56
Matsumoto, Kayo Kawasaki, JP 21 56
Nakagawa, Tadakiyo Kawasaki, JP 22 197
Takeshita, Sen Kawasaki, JP 13 69
Tokumasu, Munetaka Kawasaki, JP 22 227
Yoshida, Tomomi Kawasaki, JP 17 109

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 22, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00